Rigel Pharmaceuticals (RIGL) EBITDA (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted EBITDA of $24.42 million for Q2 2026, down 60.4% from $61.71 million a year earlier but up 95.7% from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) EBITDA (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Rigel Pharmaceuticals was $89.7 million, down 16.2% year-over-year; for FY2025, it was $127.88 million, up 384.0% from FY2024.
- In prior years, Rigel Pharmaceuticals' EBITDA was $26.42 million in FY2024, -$19.25 million in FY2023, -$54.55 million in FY2022 and -$11.33 million in FY2021.
- Quarterly EBITDA has run from a low of -$26.02 million in Q1 2022 to a high of $61.71 million in Q2 2025 over five years.
- On a year-over-year basis, EBITDA increased in three of the last five quarters, with growth averaging 146.5%.
- According to Business Quant data, EBITDA for the three prior quarters was $12.48 million (Q1 2026), $23.77 million (Q4 2025) and $29.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Rigel Pharmaceuticals | 922.04 Mn | 387.93 Mn | 70.18 Mn | 24.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.42 Mn |
| Mar 31, 2026 | 12.48 Mn |
| Dec 31, 2025 | 23.77 Mn |
| Sep 30, 2025 | 29.02 Mn |
| Jun 30, 2025 | 61.71 Mn |
| Mar 31, 2025 | 13.38 Mn |
| Dec 31, 2024 | 17.26 Mn |
| Sep 30, 2024 | 14.67 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | -6.57 Mn |
| Dec 31, 2023 | 2.26 Mn |
| Sep 30, 2023 | -4.17 Mn |
| Jun 30, 2023 | -4.97 Mn |
| Mar 31, 2023 | -12.37 Mn |
| Dec 31, 2022 | 2.36 Mn |
| Sep 30, 2022 | -18.16 Mn |
| Jun 30, 2022 | -12.73 Mn |
| Mar 31, 2022 | -26.02 Mn |
| Dec 31, 2021 | -21.01 Mn |
| Sep 30, 2021 | -19.52 Mn |
API Access
Rigel Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();